The FDA approval for Mounjaro is specifically for adults with type 2 diabetes mellitus to help control blood sugar levels, used alongside diet and exercise
Quienes recibieron semaglutida en el ltimo ensayo redujeron en promedio el 9.4% de su peso corporal, en comparacin con los que tomaron el placebo, que disminuyeron menos del 1%
The Lancet, 392(10160), 2180-2193
Ungvari Z, Gautam T, Koncz P, Henthorn JC, Pinto JT, Ballabh P, Yan H, Mitschelen M, Farley J, Sonntag WE: Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf rats
MTA does not control or guarantee the clinical judgment, treatment decisions, services, or outcomes of independent healthcare providers